novidades científicas Novo

16:13 European Cardiovascular Disease Statistics 2017
10:47 CETP inhibitor meets primary endpoint in CV outcome study
9:54 Arrhythmias and devices
14:31 Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
14:18 Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

1-Year outcomes of perioperative beta-blockade in patients undergoing noncardiac surgery

19 Março 2018

Tags:
ACC 2018

A Digital, End-to-End, Nationwide, Pragmatic Trial of Screening For Undiagnosed Atrial Fibrillation: Primary Results of the mSToPS Trial

19 Março 2018
0

Challenges Accelerator

28 Abril 2018
0

-->